善康医药冲击IPO：致力于助酒瘾等群体“脱瘾”，预计今年上市首个药物品种

七印授权

11UD1R27KATXK9M7Q0M504KPHHHWG4A3REM4JMRCYP3Q4TIB87

2023-02-27 09:00:31

article

62F553AE8B2E300301519D26C260B3753E73DCA1F039CB7E6C9F3BD82A1950BB

zh-CN

AC928D6BAB445D5EEC81A1B2B71F1BB3E34E4123

14157608

02636d79fc7c7cc37b9cb348037eec28743d030e5d570d0d69837a3587bed31880

421fa4d06b85d7040286d28c59eeb5d57e84088507164f0c04c43d1314746a714d65d7efd09137c92a6a6df1888930fea96e2a41d640c51137918da4c20a89871c

{"parameters":{"adaptation":"n","price":"100000"},"type":"cm"}

yuanben_63fc712fd19d48.52549533

原本认证

https://www.yuanben.io/article/27f629df-3d25-455d-920e-e7037568032c

{"author":"每日经济新闻","authorization_pub_key":"03040cbbeae1adf91c3efd7306d09c6005403a041f9b7405dac489d4f8126fef8c"}